avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Jun
|
ENSMUSG00000052684.3 | jun proto-oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Jun | mm10_v2_chr4_-_95052188_95052222 | 0.09 | 5.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_+_65968483 | 14.77 |
ENSMUST00000022616.6
|
Clu
|
clusterin |
chr9_-_86695897 | 9.71 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr1_+_182564994 | 9.64 |
ENSMUST00000048941.7
ENSMUST00000168514.1 |
Capn8
|
calpain 8 |
chr7_-_141276729 | 9.58 |
ENSMUST00000167263.1
ENSMUST00000080654.5 |
Cdhr5
|
cadherin-related family member 5 |
chr4_+_63356152 | 7.97 |
ENSMUST00000006687.4
|
Orm3
|
orosomucoid 3 |
chr8_-_5105232 | 7.60 |
ENSMUST00000023835.1
|
Slc10a2
|
solute carrier family 10, member 2 |
chr5_-_87254804 | 7.40 |
ENSMUST00000075858.3
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr9_+_86695542 | 6.67 |
ENSMUST00000150367.2
|
A330041J22Rik
|
RIKEN cDNA A330041J22 gene |
chr10_+_128933782 | 6.57 |
ENSMUST00000099112.2
|
Itga7
|
integrin alpha 7 |
chr1_-_180193475 | 6.44 |
ENSMUST00000160482.1
ENSMUST00000170472.1 |
Adck3
|
aarF domain containing kinase 3 |
chr14_+_66635251 | 6.36 |
ENSMUST00000159365.1
ENSMUST00000054661.1 ENSMUST00000159068.1 |
Adra1a
|
adrenergic receptor, alpha 1a |
chr3_+_138217814 | 6.32 |
ENSMUST00000090171.5
|
Adh7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr1_-_166309585 | 6.32 |
ENSMUST00000168347.1
|
5330438I03Rik
|
RIKEN cDNA 5330438I03 gene |
chr12_-_103904887 | 6.26 |
ENSMUST00000074051.5
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr12_-_103773592 | 6.08 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr9_+_7445822 | 6.00 |
ENSMUST00000034497.6
|
Mmp3
|
matrix metallopeptidase 3 |
chr9_-_120023558 | 5.92 |
ENSMUST00000111635.2
|
Xirp1
|
xin actin-binding repeat containing 1 |
chr6_+_17463927 | 5.74 |
ENSMUST00000115442.1
|
Met
|
met proto-oncogene |
chr1_+_107589997 | 5.48 |
ENSMUST00000112706.2
ENSMUST00000000514.4 |
Serpinb8
|
serine (or cysteine) peptidase inhibitor, clade B, member 8 |
chr7_+_127800844 | 5.31 |
ENSMUST00000106271.1
ENSMUST00000138432.1 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr8_-_110039330 | 5.11 |
ENSMUST00000109222.2
|
Chst4
|
carbohydrate (chondroitin 6/keratan) sulfotransferase 4 |
chr5_-_24758008 | 5.03 |
ENSMUST00000047119.4
|
Crygn
|
crystallin, gamma N |
chr12_-_103956891 | 4.90 |
ENSMUST00000085054.4
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr7_-_29248375 | 4.59 |
ENSMUST00000032808.4
|
2200002D01Rik
|
RIKEN cDNA 2200002D01 gene |
chr5_-_66080971 | 4.52 |
ENSMUST00000127275.1
ENSMUST00000113724.1 |
Rbm47
|
RNA binding motif protein 47 |
chr1_-_180193653 | 4.51 |
ENSMUST00000159914.1
|
Adck3
|
aarF domain containing kinase 3 |
chr3_+_100825452 | 4.50 |
ENSMUST00000054791.7
|
Vtcn1
|
V-set domain containing T cell activation inhibitor 1 |
chr2_-_25461021 | 4.46 |
ENSMUST00000151239.1
|
BC029214
|
cDNA sequence BC029214 |
chr2_-_25461094 | 4.45 |
ENSMUST00000114261.2
|
BC029214
|
cDNA sequence BC029214 |
chr12_-_103863551 | 4.41 |
ENSMUST00000085056.6
ENSMUST00000072876.5 ENSMUST00000124717.1 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr19_+_8989277 | 4.33 |
ENSMUST00000092955.3
ENSMUST00000092956.2 |
Ahnak
|
AHNAK nucleoprotein (desmoyokin) |
chr19_-_4042165 | 4.18 |
ENSMUST00000042700.9
|
Gstp2
|
glutathione S-transferase, pi 2 |
chr7_+_30553263 | 4.17 |
ENSMUST00000044048.7
|
Hspb6
|
heat shock protein, alpha-crystallin-related, B6 |
chr10_-_128589650 | 4.14 |
ENSMUST00000082059.6
|
Erbb3
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
chr17_+_43953191 | 4.10 |
ENSMUST00000044792.4
|
Rcan2
|
regulator of calcineurin 2 |
chr11_+_76904475 | 4.02 |
ENSMUST00000142166.1
|
Tmigd1
|
transmembrane and immunoglobulin domain containing 1 |
chr13_+_30659999 | 4.02 |
ENSMUST00000091672.6
ENSMUST00000110310.1 ENSMUST00000095914.5 |
Dusp22
|
dual specificity phosphatase 22 |
chr7_-_80401707 | 3.98 |
ENSMUST00000120753.1
|
Furin
|
furin (paired basic amino acid cleaving enzyme) |
chr9_+_7347374 | 3.94 |
ENSMUST00000065079.5
ENSMUST00000005950.5 |
Mmp12
|
matrix metallopeptidase 12 |
chr3_+_123267445 | 3.89 |
ENSMUST00000047923.7
|
Sec24d
|
Sec24 related gene family, member D (S. cerevisiae) |
chr14_+_27622433 | 3.88 |
ENSMUST00000090302.5
|
Erc2
|
ELKS/RAB6-interacting/CAST family member 2 |
chr2_+_69380431 | 3.87 |
ENSMUST00000063690.3
|
Dhrs9
|
dehydrogenase/reductase (SDR family) member 9 |
chr15_-_3303521 | 3.86 |
ENSMUST00000165386.1
|
Ccdc152
|
coiled-coil domain containing 152 |
chr7_+_141338880 | 3.84 |
ENSMUST00000026577.6
|
Eps8l2
|
EPS8-like 2 |
chr4_-_140665891 | 3.82 |
ENSMUST00000069623.5
|
Arhgef10l
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr6_+_17463749 | 3.81 |
ENSMUST00000115443.1
|
Met
|
met proto-oncogene |
chr12_-_103738158 | 3.76 |
ENSMUST00000095450.4
|
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr10_+_127776374 | 3.74 |
ENSMUST00000136223.1
ENSMUST00000052652.6 |
Rdh9
|
retinol dehydrogenase 9 |
chr7_-_133782721 | 3.74 |
ENSMUST00000063669.1
|
Dhx32
|
DEAH (Asp-Glu-Ala-His) box polypeptide 32 |
chr7_-_127946725 | 3.73 |
ENSMUST00000118755.1
ENSMUST00000094026.3 |
Prss36
|
protease, serine, 36 |
chr8_+_36489191 | 3.68 |
ENSMUST00000171777.1
|
6430573F11Rik
|
RIKEN cDNA 6430573F11 gene |
chr3_+_121723515 | 3.66 |
ENSMUST00000029771.8
|
F3
|
coagulation factor III |
chr17_+_43952999 | 3.64 |
ENSMUST00000177857.1
|
Rcan2
|
regulator of calcineurin 2 |
chr18_-_31820413 | 3.63 |
ENSMUST00000165131.2
|
Gm6665
|
predicted gene 6665 |
chr11_-_60036917 | 3.58 |
ENSMUST00000102692.3
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr18_+_20944607 | 3.58 |
ENSMUST00000050004.1
|
Rnf125
|
ring finger protein 125 |
chr15_-_74728011 | 3.57 |
ENSMUST00000023261.2
|
Slurp1
|
secreted Ly6/Plaur domain containing 1 |
chr1_+_87594545 | 3.57 |
ENSMUST00000165109.1
ENSMUST00000070898.5 |
Neu2
|
neuraminidase 2 |
chr2_+_162987502 | 3.52 |
ENSMUST00000117123.1
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr1_+_165769392 | 3.48 |
ENSMUST00000040298.4
|
Creg1
|
cellular repressor of E1A-stimulated genes 1 |
chr5_-_86518578 | 3.43 |
ENSMUST00000134179.1
|
Tmprss11g
|
transmembrane protease, serine 11g |
chr1_-_155527083 | 3.42 |
ENSMUST00000097531.2
|
Gm5532
|
predicted gene 5532 |
chr11_+_101082565 | 3.40 |
ENSMUST00000001806.3
ENSMUST00000107308.3 |
Coasy
|
Coenzyme A synthase |
chr2_+_162987330 | 3.38 |
ENSMUST00000018012.7
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr7_-_44670820 | 3.37 |
ENSMUST00000048102.7
|
Myh14
|
myosin, heavy polypeptide 14 |
chr9_-_106476372 | 3.34 |
ENSMUST00000123555.1
ENSMUST00000125850.1 |
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr10_-_44004846 | 3.31 |
ENSMUST00000020017.8
|
Aim1
|
absent in melanoma 1 |
chr19_+_5877794 | 3.29 |
ENSMUST00000145200.1
ENSMUST00000025732.7 ENSMUST00000125114.1 ENSMUST00000155697.1 |
Slc25a45
|
solute carrier family 25, member 45 |
chrX_+_98149666 | 3.27 |
ENSMUST00000052837.7
|
Ar
|
androgen receptor |
chr3_-_85722474 | 3.27 |
ENSMUST00000119077.1
|
Fam160a1
|
family with sequence similarity 160, member A1 |
chr18_-_35627223 | 3.22 |
ENSMUST00000025212.5
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr6_+_17463826 | 3.19 |
ENSMUST00000140070.1
|
Met
|
met proto-oncogene |
chr4_+_152008803 | 3.07 |
ENSMUST00000097773.3
|
Klhl21
|
kelch-like 21 |
chr9_-_106476590 | 3.05 |
ENSMUST00000112479.2
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr17_-_31165045 | 3.03 |
ENSMUST00000024831.6
|
Tff1
|
trefoil factor 1 |
chr7_-_126584220 | 2.99 |
ENSMUST00000128970.1
ENSMUST00000116269.2 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr5_-_108675569 | 2.96 |
ENSMUST00000051757.7
|
Slc26a1
|
solute carrier family 26 (sulfate transporter), member 1 |
chr17_+_85028347 | 2.94 |
ENSMUST00000024944.7
|
Slc3a1
|
solute carrier family 3, member 1 |
chr15_-_76014318 | 2.92 |
ENSMUST00000060807.5
|
Fam83h
|
family with sequence similarity 83, member H |
chr6_+_124996681 | 2.91 |
ENSMUST00000032479.4
|
Pianp
|
PILR alpha associated neural protein |
chr17_+_26113286 | 2.88 |
ENSMUST00000025010.7
|
Tmem8
|
transmembrane protein 8 (five membrane-spanning domains) |
chr7_+_67647405 | 2.86 |
ENSMUST00000032774.8
ENSMUST00000107471.1 |
Ttc23
|
tetratricopeptide repeat domain 23 |
chr7_-_4971168 | 2.85 |
ENSMUST00000133272.1
|
Gm1078
|
predicted gene 1078 |
chr6_-_3968357 | 2.80 |
ENSMUST00000031674.8
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr4_-_148151646 | 2.78 |
ENSMUST00000132083.1
|
Fbxo6
|
F-box protein 6 |
chrX_+_7722267 | 2.74 |
ENSMUST00000125991.1
ENSMUST00000148624.1 |
Wdr45
|
WD repeat domain 45 |
chr7_+_141338963 | 2.67 |
ENSMUST00000143633.1
|
Eps8l2
|
EPS8-like 2 |
chrX_-_147429189 | 2.61 |
ENSMUST00000033646.2
|
Il13ra2
|
interleukin 13 receptor, alpha 2 |
chrX_-_74023745 | 2.60 |
ENSMUST00000114353.3
ENSMUST00000101458.2 |
Irak1
|
interleukin-1 receptor-associated kinase 1 |
chrX_+_7722214 | 2.55 |
ENSMUST00000043045.2
ENSMUST00000116634.1 ENSMUST00000115689.3 ENSMUST00000131077.1 ENSMUST00000115688.1 ENSMUST00000116633.1 |
Wdr45
|
WD repeat domain 45 |
chr10_-_81427114 | 2.53 |
ENSMUST00000078185.7
ENSMUST00000020461.8 ENSMUST00000105321.3 |
Nfic
|
nuclear factor I/C |
chr12_-_85288419 | 2.47 |
ENSMUST00000121930.1
|
Acyp1
|
acylphosphatase 1, erythrocyte (common) type |
chr18_-_35498856 | 2.46 |
ENSMUST00000025215.8
|
Sil1
|
endoplasmic reticulum chaperone SIL1 homolog (S. cerevisiae) |
chr2_+_25395866 | 2.42 |
ENSMUST00000028328.2
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr13_-_8871751 | 2.40 |
ENSMUST00000175958.1
|
Wdr37
|
WD repeat domain 37 |
chr9_+_7272514 | 2.38 |
ENSMUST00000015394.8
|
Mmp13
|
matrix metallopeptidase 13 |
chr11_-_50210765 | 2.37 |
ENSMUST00000143379.1
ENSMUST00000015981.5 ENSMUST00000102774.4 |
Sqstm1
|
sequestosome 1 |
chr4_-_140648736 | 2.36 |
ENSMUST00000039204.3
ENSMUST00000105799.1 ENSMUST00000097820.2 |
Arhgef10l
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chrX_+_164269371 | 2.35 |
ENSMUST00000145412.1
ENSMUST00000033749.7 |
Pir
|
pirin |
chr13_-_54611274 | 2.31 |
ENSMUST00000049575.7
|
Cltb
|
clathrin, light polypeptide (Lcb) |
chr15_-_3979432 | 2.30 |
ENSMUST00000022791.8
|
Fbxo4
|
F-box protein 4 |
chr15_-_11399594 | 2.29 |
ENSMUST00000022849.5
|
Tars
|
threonyl-tRNA synthetase |
chr11_+_87592145 | 2.29 |
ENSMUST00000103179.3
ENSMUST00000092802.5 ENSMUST00000146871.1 |
Mtmr4
|
myotubularin related protein 4 |
chr2_+_143915273 | 2.28 |
ENSMUST00000103172.3
|
Dstn
|
destrin |
chr15_+_44196135 | 2.26 |
ENSMUST00000038856.6
ENSMUST00000110289.3 |
Trhr
|
thyrotropin releasing hormone receptor |
chr2_+_160880642 | 2.21 |
ENSMUST00000109456.2
|
Lpin3
|
lipin 3 |
chr13_+_75839868 | 2.20 |
ENSMUST00000022082.7
|
Glrx
|
glutaredoxin |
chr9_+_37613806 | 2.20 |
ENSMUST00000002007.3
|
Siae
|
sialic acid acetylesterase |
chr16_-_56717446 | 2.19 |
ENSMUST00000065515.7
|
Tfg
|
Trk-fused gene |
chr13_-_54611332 | 2.17 |
ENSMUST00000091609.4
|
Cltb
|
clathrin, light polypeptide (Lcb) |
chr17_-_23998094 | 2.16 |
ENSMUST00000041649.6
|
Prss22
|
protease, serine, 22 |
chr4_-_45489794 | 2.16 |
ENSMUST00000146236.1
|
Shb
|
src homology 2 domain-containing transforming protein B |
chr14_-_34310503 | 2.15 |
ENSMUST00000111917.1
|
Fam35a
|
family with sequence similarity 35, member A |
chr19_-_11818806 | 2.14 |
ENSMUST00000075304.6
|
Stx3
|
syntaxin 3 |
chr6_+_82052307 | 2.13 |
ENSMUST00000149023.1
|
Eva1a
|
eva-1 homolog A (C. elegans) |
chr2_-_77703252 | 2.12 |
ENSMUST00000171063.1
|
Zfp385b
|
zinc finger protein 385B |
chr4_-_141723401 | 2.10 |
ENSMUST00000102484.4
ENSMUST00000177592.1 |
Ddi2
Rsc1a1
|
DNA-damage inducible protein 2 regulatory solute carrier protein, family 1, member 1 |
chr11_+_94328242 | 2.07 |
ENSMUST00000021227.5
|
Ankrd40
|
ankyrin repeat domain 40 |
chr11_+_121146143 | 2.04 |
ENSMUST00000039088.8
ENSMUST00000155694.1 |
Tex19.1
|
testis expressed gene 19.1 |
chr16_-_56717286 | 2.01 |
ENSMUST00000121554.1
ENSMUST00000128551.1 |
Tfg
|
Trk-fused gene |
chr1_+_33908172 | 1.99 |
ENSMUST00000182513.1
ENSMUST00000183034.1 |
Dst
|
dystonin |
chr15_-_91049823 | 1.97 |
ENSMUST00000088614.5
ENSMUST00000100304.4 ENSMUST00000067205.8 ENSMUST00000109288.2 ENSMUST00000109287.2 |
Kif21a
|
kinesin family member 21A |
chr3_-_88177671 | 1.97 |
ENSMUST00000181837.1
|
1700113A16Rik
|
RIKEN cDNA 1700113A16 gene |
chr5_-_62766153 | 1.96 |
ENSMUST00000076623.4
|
Arap2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr11_+_9118070 | 1.96 |
ENSMUST00000020677.1
ENSMUST00000101525.2 ENSMUST00000170444.1 |
Upp1
|
uridine phosphorylase 1 |
chr16_+_90220742 | 1.96 |
ENSMUST00000023707.9
|
Sod1
|
superoxide dismutase 1, soluble |
chr1_+_164115264 | 1.95 |
ENSMUST00000162746.1
|
Selp
|
selectin, platelet |
chr17_-_24644933 | 1.94 |
ENSMUST00000019684.5
|
Slc9a3r2
|
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 |
chrX_-_74023908 | 1.94 |
ENSMUST00000033769.8
ENSMUST00000114352.1 ENSMUST00000068286.5 ENSMUST00000114360.3 ENSMUST00000114354.3 |
Irak1
|
interleukin-1 receptor-associated kinase 1 |
chr7_-_126584578 | 1.93 |
ENSMUST00000150311.1
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr11_+_94327984 | 1.89 |
ENSMUST00000107818.2
ENSMUST00000051221.6 |
Ankrd40
|
ankyrin repeat domain 40 |
chr19_-_36736653 | 1.84 |
ENSMUST00000087321.2
|
Ppp1r3c
|
protein phosphatase 1, regulatory (inhibitor) subunit 3C |
chr2_-_102400863 | 1.84 |
ENSMUST00000102573.1
|
Trim44
|
tripartite motif-containing 44 |
chr5_-_148552783 | 1.82 |
ENSMUST00000079324.7
ENSMUST00000164904.1 |
Ubl3
|
ubiquitin-like 3 |
chr7_-_18432033 | 1.82 |
ENSMUST00000019291.6
|
Psg28
|
pregnancy-specific glycoprotein 28 |
chr13_-_119738394 | 1.82 |
ENSMUST00000178973.1
|
Nim1
|
serine/threonine-protein kinase NIM1 |
chr11_-_120630516 | 1.80 |
ENSMUST00000106181.1
|
Mafg
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
chr4_-_148151878 | 1.80 |
ENSMUST00000105706.1
ENSMUST00000030858.7 ENSMUST00000134261.1 |
Fbxo6
|
F-box protein 6 |
chr2_+_152105722 | 1.78 |
ENSMUST00000099225.2
|
Srxn1
|
sulfiredoxin 1 homolog (S. cerevisiae) |
chr9_-_20728219 | 1.77 |
ENSMUST00000034692.7
|
Olfm2
|
olfactomedin 2 |
chr2_+_69670100 | 1.75 |
ENSMUST00000100050.3
|
Klhl41
|
kelch-like 41 |
chrX_-_8132770 | 1.75 |
ENSMUST00000130832.1
ENSMUST00000033506.6 ENSMUST00000115623.1 ENSMUST00000153839.1 |
Wdr13
|
WD repeat domain 13 |
chrX_+_73675500 | 1.73 |
ENSMUST00000171398.1
|
Slc6a8
|
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
chr2_+_167421706 | 1.69 |
ENSMUST00000047815.6
ENSMUST00000109218.1 ENSMUST00000073873.3 |
Slc9a8
|
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
chr14_-_55758458 | 1.69 |
ENSMUST00000001497.7
|
Cideb
|
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
chr9_+_108953597 | 1.68 |
ENSMUST00000026740.5
|
Col7a1
|
collagen, type VII, alpha 1 |
chr11_+_76904513 | 1.67 |
ENSMUST00000072633.3
|
Tmigd1
|
transmembrane and immunoglobulin domain containing 1 |
chr7_-_68353182 | 1.66 |
ENSMUST00000123509.1
ENSMUST00000129965.1 |
Gm16158
|
predicted gene 16158 |
chr8_-_61591130 | 1.65 |
ENSMUST00000135439.1
ENSMUST00000121200.1 |
Palld
|
palladin, cytoskeletal associated protein |
chr11_-_70015346 | 1.65 |
ENSMUST00000018718.7
ENSMUST00000102574.3 |
Acadvl
|
acyl-Coenzyme A dehydrogenase, very long chain |
chr2_+_145785980 | 1.63 |
ENSMUST00000110005.1
ENSMUST00000094480.4 |
Rin2
|
Ras and Rab interactor 2 |
chr3_-_57294880 | 1.61 |
ENSMUST00000171384.1
|
Tm4sf1
|
transmembrane 4 superfamily member 1 |
chr14_+_120478443 | 1.60 |
ENSMUST00000062117.6
|
Rap2a
|
RAS related protein 2a |
chr11_+_87582201 | 1.60 |
ENSMUST00000133202.1
|
Sept4
|
septin 4 |
chr4_+_42158092 | 1.58 |
ENSMUST00000098122.2
|
Gm13306
|
predicted gene 13306 |
chr11_+_95842283 | 1.57 |
ENSMUST00000107714.2
ENSMUST00000107711.1 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr11_+_117232254 | 1.57 |
ENSMUST00000106354.2
|
Sept9
|
septin 9 |
chr2_-_103372725 | 1.56 |
ENSMUST00000139065.1
|
A930006I01Rik
|
RIKEN cDNA A930006I01 gene |
chr7_-_101581161 | 1.53 |
ENSMUST00000063920.2
|
Art2b
|
ADP-ribosyltransferase 2b |
chr15_-_97767644 | 1.53 |
ENSMUST00000128775.2
ENSMUST00000134885.2 |
Rapgef3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr10_+_26078255 | 1.52 |
ENSMUST00000041011.3
|
Gm9767
|
predicted gene 9767 |
chr7_+_127244511 | 1.51 |
ENSMUST00000052509.4
|
Zfp771
|
zinc finger protein 771 |
chr7_+_55842071 | 1.51 |
ENSMUST00000032629.9
ENSMUST00000173783.1 ENSMUST00000085255.4 ENSMUST00000163845.2 |
Cyfip1
|
cytoplasmic FMR1 interacting protein 1 |
chr11_-_120467414 | 1.49 |
ENSMUST00000076921.6
|
Arl16
|
ADP-ribosylation factor-like 16 |
chr15_-_33687840 | 1.47 |
ENSMUST00000042021.3
|
Tspyl5
|
testis-specific protein, Y-encoded-like 5 |
chr8_+_107293500 | 1.45 |
ENSMUST00000151114.1
ENSMUST00000075922.4 ENSMUST00000125721.1 |
Nfat5
|
nuclear factor of activated T cells 5 |
chr8_-_105966038 | 1.44 |
ENSMUST00000116429.2
ENSMUST00000034370.9 |
Slc12a4
|
solute carrier family 12, member 4 |
chr16_+_20548577 | 1.41 |
ENSMUST00000003319.5
|
Abcf3
|
ATP-binding cassette, sub-family F (GCN20), member 3 |
chr14_+_101840602 | 1.40 |
ENSMUST00000159314.1
|
Lmo7
|
LIM domain only 7 |
chr9_+_32224246 | 1.40 |
ENSMUST00000168954.2
|
Arhgap32
|
Rho GTPase activating protein 32 |
chr3_-_89402650 | 1.40 |
ENSMUST00000168325.1
ENSMUST00000057431.5 |
Lenep
|
lens epithelial protein |
chr17_-_42742167 | 1.38 |
ENSMUST00000113614.2
|
Gpr111
|
G protein-coupled receptor 111 |
chr2_+_11705712 | 1.37 |
ENSMUST00000138856.1
ENSMUST00000078834.5 ENSMUST00000114834.3 ENSMUST00000114833.3 ENSMUST00000114831.2 ENSMUST00000114832.2 |
Il15ra
|
interleukin 15 receptor, alpha chain |
chr6_-_113434757 | 1.37 |
ENSMUST00000113091.1
|
Cidec
|
cell death-inducing DFFA-like effector c |
chr2_+_20737306 | 1.36 |
ENSMUST00000114606.1
ENSMUST00000114608.1 |
Etl4
|
enhancer trap locus 4 |
chr11_-_31671863 | 1.35 |
ENSMUST00000058060.7
|
Bod1
|
biorientation of chromosomes in cell division 1 |
chr6_-_122856151 | 1.35 |
ENSMUST00000042081.8
|
C3ar1
|
complement component 3a receptor 1 |
chr1_+_128244122 | 1.34 |
ENSMUST00000027592.3
|
Ubxn4
|
UBX domain protein 4 |
chr14_-_8259325 | 1.34 |
ENSMUST00000164598.1
|
Acox2
|
acyl-Coenzyme A oxidase 2, branched chain |
chr11_-_97150025 | 1.34 |
ENSMUST00000118375.1
|
Tbkbp1
|
TBK1 binding protein 1 |
chr11_+_95842668 | 1.30 |
ENSMUST00000100532.3
ENSMUST00000036088.4 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr6_-_113434529 | 1.30 |
ENSMUST00000133348.1
|
Cidec
|
cell death-inducing DFFA-like effector c |
chr5_+_117363513 | 1.30 |
ENSMUST00000111959.1
|
Wsb2
|
WD repeat and SOCS box-containing 2 |
chr9_-_109059216 | 1.29 |
ENSMUST00000112053.1
|
Trex1
|
three prime repair exonuclease 1 |
chr7_-_4970961 | 1.28 |
ENSMUST00000144863.1
|
Gm1078
|
predicted gene 1078 |
chr11_-_95842409 | 1.27 |
ENSMUST00000059026.3
|
Abi3
|
ABI gene family, member 3 |
chr2_+_11705437 | 1.25 |
ENSMUST00000148748.1
|
Il15ra
|
interleukin 15 receptor, alpha chain |
chr14_-_8258800 | 1.23 |
ENSMUST00000022271.7
|
Acox2
|
acyl-Coenzyme A oxidase 2, branched chain |
chr11_+_73267388 | 1.23 |
ENSMUST00000049676.2
|
Trpv3
|
transient receptor potential cation channel, subfamily V, member 3 |
chr10_+_86779000 | 1.23 |
ENSMUST00000099396.2
|
Nt5dc3
|
5'-nucleotidase domain containing 3 |
chr9_+_108953578 | 1.22 |
ENSMUST00000112070.1
|
Col7a1
|
collagen, type VII, alpha 1 |
chr11_+_80428598 | 1.21 |
ENSMUST00000173938.1
ENSMUST00000017572.7 |
Psmd11
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
chr11_-_93968293 | 1.21 |
ENSMUST00000170303.1
|
Gm20390
|
predicted gene 20390 |
chr10_+_24447468 | 1.21 |
ENSMUST00000134627.1
|
Gm15271
|
predicted gene 15271 |
chr2_+_11705355 | 1.20 |
ENSMUST00000128156.2
|
Il15ra
|
interleukin 15 receptor, alpha chain |
chr11_-_93968242 | 1.20 |
ENSMUST00000107844.2
|
Nme1
|
NME/NM23 nucleoside diphosphate kinase 1 |
chr18_+_61639542 | 1.19 |
ENSMUST00000183083.1
ENSMUST00000183087.1 |
Gm20748
|
predicted gene, 20748 |
chr12_+_75308308 | 1.19 |
ENSMUST00000118602.1
ENSMUST00000118966.1 ENSMUST00000055390.5 |
Rhoj
|
ras homolog gene family, member J |
chr17_-_45592485 | 1.17 |
ENSMUST00000166119.1
|
Slc29a1
|
solute carrier family 29 (nucleoside transporters), member 1 |
chr1_-_120074023 | 1.15 |
ENSMUST00000056089.7
|
Tmem37
|
transmembrane protein 37 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 14.8 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
2.1 | 6.4 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
2.1 | 6.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.9 | 9.6 | GO:1904970 | brush border assembly(GO:1904970) |
1.8 | 12.7 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.7 | 5.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.6 | 6.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.4 | 9.7 | GO:0006108 | malate metabolic process(GO:0006108) regulation of NADP metabolic process(GO:1902031) |
1.2 | 3.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.1 | 3.3 | GO:0060748 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.1 | 7.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 3.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.0 | 4.0 | GO:0090472 | dibasic protein processing(GO:0090472) |
1.0 | 4.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.8 | 2.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.7 | 2.0 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.7 | 3.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.7 | 2.6 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.6 | 4.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.6 | 6.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.6 | 3.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 2.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.6 | 5.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 1.7 | GO:0015881 | creatine transport(GO:0015881) |
0.6 | 2.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.5 | 4.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) positive regulation of interleukin-2 secretion(GO:1900042) |
0.5 | 6.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 4.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 14.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 3.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.4 | 2.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 2.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.4 | 1.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 3.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 1.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.3 | 3.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.3 | 2.2 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 2.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.5 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 1.2 | GO:0035938 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.3 | 2.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.3 | 2.6 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.3 | 7.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 2.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 1.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 3.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 5.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.1 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.3 | 2.1 | GO:0098881 | synaptic vesicle docking(GO:0016081) exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.3 | 1.8 | GO:1901098 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) positive regulation of autophagosome maturation(GO:1901098) |
0.3 | 3.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 2.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.2 | 6.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 4.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.3 | GO:0002461 | complement receptor mediated signaling pathway(GO:0002430) tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 0.9 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 2.2 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 2.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 3.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 3.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 2.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 2.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.0 | GO:0048861 | histone H3-K27 acetylation(GO:0043974) leukemia inhibitory factor signaling pathway(GO:0048861) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.6 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.2 | 1.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 5.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 1.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 3.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 1.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 2.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.1 | 1.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 4.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 6.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 2.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.3 | GO:0072276 | cell migration involved in vasculogenesis(GO:0035441) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.1 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 3.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 1.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 2.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.7 | GO:0051036 | regulation of endosome size(GO:0051036) receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.3 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 4.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 1.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 1.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 2.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 23.0 | GO:0043434 | response to peptide hormone(GO:0043434) |
0.1 | 0.8 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 5.9 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 2.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 2.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 5.8 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 5.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 1.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 4.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 1.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 1.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 1.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 3.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 3.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 3.1 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 1.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.3 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 1.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 1.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 1.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.8 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.3 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:2001179 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 1.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.9 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.6 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.0 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.1 | 14.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 9.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.9 | 4.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.9 | 6.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.8 | 2.4 | GO:0044753 | amphisome(GO:0044753) |
0.6 | 3.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 8.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.5 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 3.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 5.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 4.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 5.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 2.0 | GO:0031673 | H zone(GO:0031673) |
0.3 | 3.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 3.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.7 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.2 | 1.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.2 | 3.3 | GO:0031105 | septin complex(GO:0031105) |
0.2 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.8 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 6.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 11.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 4.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 10.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 2.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 3.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.9 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 8.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 6.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 4.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 2.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 4.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 1.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 4.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 6.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 6.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 3.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 2.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 12.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 3.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 3.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 3.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 1.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.7 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
3.2 | 12.7 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
2.1 | 6.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.6 | 6.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.3 | 7.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 3.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.1 | 3.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.1 | 7.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.1 | 3.2 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.9 | 3.6 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.9 | 5.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.8 | 2.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 2.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 2.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 3.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 6.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 2.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.6 | 14.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 3.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.6 | 1.7 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.5 | 1.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.5 | 3.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 2.0 | GO:0042806 | fucose binding(GO:0042806) |
0.4 | 10.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 2.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.4 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 5.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 4.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 3.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 2.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 4.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.9 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.3 | 1.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.3 | 6.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 4.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 38.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 2.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 2.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 4.7 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 3.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 7.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 1.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 3.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 5.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 3.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.7 | GO:1903135 | cupric ion binding(GO:1903135) |
0.2 | 3.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 2.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 4.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 4.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.5 | GO:0051381 | histamine binding(GO:0051381) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 2.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 5.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 11.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 3.1 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 2.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 3.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 2.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 4.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 4.0 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 2.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 2.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 6.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 5.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 2.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 2.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 2.3 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.2 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 3.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 2.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 8.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 2.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 2.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 9.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 2.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 6.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 1.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 5.4 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 1.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 2.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 2.9 | GO:0048037 | cofactor binding(GO:0048037) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 14.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 4.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 19.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 11.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 7.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 13.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 4.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 4.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 6.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 7.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 8.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.5 | 5.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 15.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 2.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 4.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 3.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 3.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 5.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 6.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 2.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 3.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 6.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 9.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 9.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 3.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 3.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 2.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 4.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 2.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.9 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |